Island Pharmaceuticals Ltd has released a press release.
Response to ASX Query Letter
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- $9m placement to advance US biodefence opportunity
- FDA confirms Galidesivir approval pathway
- Quarterly Appendix 4C and Activities Report
- US Patent Granted for Galidesivir in filoviridae viruses
- Ongoing engagement with the US FDA
Later from Island Pharmaceuticals
- Appendix 4D & Half-Year Financial Statements
- Trading Halt
- US Government collaboration for Galidesivir development
- Antiviral pipeline expansion through strategic collaboration
- Island Bolsters US Biodefence Readiness Ahead of Trials
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals